IEQ Capital’s Zosano Pharma Corporation ZSAN Stock Holding History

IEQ Capital’s Portfolio ZSAN Stock Details ZSAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,481	Closed	-$79K	–	442
2019 Q4	$79K	Buy	+1,481	New	+$91.4K	0.01%	393

Other funds holding ZSAN

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

BBVA

Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

IEQ Capital's ZSAN Position: Q1 2020 in Review

IEQ Capital sold out of Zosano Pharma Corporation (ZSAN) in Q1 2020, closing a stake of 1,481 shares — an estimated $79K sold.

IEQ Capital first reported a position in ZSAN in Q4 2019 and held it in 1 quarter. The position peaked at $79K in Q4 2019. 29 funds tracked by Wall St. Rank hold ZSAN as of Q1 2020.

IEQ Capital reported no remaining Zosano Pharma Corporation position as of Q1 2020 after selling out during the quarter.
IEQ Capital sold 1,481 Zosano Pharma Corporation shares in Q1 2020, an estimated $79K.
IEQ Capital first reported a position in Zosano Pharma Corporation in Q4 2019 and held it in 1 quarter.
IEQ Capital's Zosano Pharma Corporation position peaked at $79K in Q4 2019.
29 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q1 2020.

Based on IEQ Capital's 13F filing for Q1 2020, filed 7 May 2020.